Helping Pay Your Medicine
At Bristol-Myers Squibb, we are firmly focused on our Mission to discover,
develop and deliver innovative medicines that help patients prevail over serious
diseases. In addition, we are steadfast in our Commitment to economic, social
and environmental sustainability.
Integrity is the foundation from which we operate. As a Biopharma leader, we
take our responsibilities seriously, and always strive to do the right thing for
the benefit of the patients we serve around the world, our company, our
employees, our shareholders and our communities.
We know that all too often, patients worldwide face health disparities and
barriers to health care. Certain populations – particularly the urban and rural
poor, women, racial and ethnic minorities, and marginalized people – experience
worse health outcomes compared with others.
Global health care challenges are daunting. We recognize that as we provide
innovative medicines for patients in need we must work together with
governments, payers, patients, health care providers and other stakeholders to
develop workable and sustainable solutions. As part of our Mission to help
patients prevail, this is what we do.
Patient Assistance Programme
concerns, Providing hope.
BMS is committed to helping patients. BMS worldwide conducts several
programs to reduce health disparities and to enhance global access to medicine.
Since 2006, BMS in India has rolled out several patient assistance programs in
different therapeutic area to support:
In providing medicine to eligible individuals.
Delivery of medicine to patient’s doorstep without any additional cost.
Value Added services such as monthly reminder and educational booklets.
The benefit of convenient monthly installments for your therapy.
Partnering with Patients and Physicians to Enhance Access and Improve
Compliance: Working Locally to Help Patients Get the Medicines They Need
Bristol-Myers Squibb has developed a number of market-specific initiatives in
India to expand access to its medicines and make them more affordable. For
example, programs offer special incentives to refill drug prescriptions for
The company uses a third-party M/s Kartavya Healtheon Private Limited, patient
support agency, to manage certain patient-related efforts, including programs to
improve compliance and medicine availability for hepatitis B and CML patients.
In these programs, the Oasis agency delivers medicines to patients and also
provides disease education materials and counseling services. Patient support
materials are translated into nine languages other than English. In addition,
screening camps in India are supported by Bristol-Myers Squibb to uncover cases
of hepatitis B.
For more information on our Patient Support/Assistance Programme in India,
please get in touch with OASIS call center services. These services are
available only to eligible patients under the criteria set down by BMS in India.
If you have any queries about the program, please feel free to contact Oasis